| Institution: | From the Section of Hematology-Oncology, Department of Medicine, University of Illinois at Chicago and West Side Veterans Affairs Hospital, IL; the Department of Medical Genetics and Microbiology, University of Toronto, Ontario, Canada; the Division of Hematology-Oncology, Loyola University of Chicago and Hines VA Hospital, Maywood, IL; the Department of Pathology, University of Tennessee, Memphis; Oncology Center, Johns Hopkins University, Baltimore, MD; and Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, MA. |
